Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Banco de datos
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
2.
Cancer Sci ; 98(7): 992-9, 2007 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-17459058

RESUMEN

Directed movement of normal cells occurs when actin-related protein 2 and 3 complex (Arp2/3 complex) triggers the actin polymerization that forms lamellipodia immediately after binding to WAVE2. In order to determine whether the same mechanism correlates with liver metastasis from colorectal cancer, paired mirror sections of 154 cancer specimens (29 cases with liver metastasis and 125 cases without liver metastasis in which T factor, gender, primary tumor site, and age at operation were matched) were examined immunohistochemically for the localization of Arp2 and WAVE2. Expression of both Arp2 and WAVE2 was detected in the same cancer cells in 55 (35.7%) of the 154 cases, but not detected in the normal colonic epithelial cells. Univariate analysis showed that the colocalization was significantly predictive of liver metastasis (risk ratio [RR] 8.760. Likewise, histological grade (RR 2.46), lymphatic invasion (RR 9.95), and tumor budding (RR 4.00) were significant predictors. Among these, colocalization and lymphatic invasion were shown to be independent risk factors by multivariate analysis. Another 59 colorectal specimens were examined for mRNA expression of Arp2 by real time polymerase chain reaction. High mRNA levels of Arp2, that in situ hybridization revealed to be expressed by the cancer cells, were significantly associated with liver metastasis. However, its effect was absorbed by the influence of risk of the colocalization that is closely related to high expression of Arp2. These results indicate that the colocalization of Arp2 and WAVE2 is an independent risk factor for liver metastasis of colorectal carcinoma.


Asunto(s)
Proteína 2 Relacionada con la Actina/fisiología , Proteína 3 Relacionada con la Actina/fisiología , Neoplasias Colorrectales/patología , Neoplasias Hepáticas/secundario , Familia de Proteínas del Síndrome de Wiskott-Aldrich/fisiología , Proteína 2 Relacionada con la Actina/genética , Proteína 3 Relacionada con la Actina/genética , Actinas/fisiología , Adenocarcinoma/irrigación sanguínea , Adenocarcinoma/patología , Neoplasias Colorrectales/irrigación sanguínea , Cartilla de ADN , Femenino , Humanos , Inmunohistoquímica , Hibridación in Situ , Neoplasias Hepáticas/irrigación sanguínea , Neoplasias Hepáticas/patología , Masculino , Invasividad Neoplásica , Reacción en Cadena de la Polimerasa , ARN Mensajero/genética , Familia de Proteínas del Síndrome de Wiskott-Aldrich/genética
3.
Mod Pathol ; 17(4): 461-7, 2004 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-14990971

RESUMEN

Increased motility is one of the characteristics of cancer cells, and actin polymerization and disassembly are essential for cellular motility. Since actin-related protein (Arp) 2/3 complex acts as a nucleus for actin polymerization, in this study, we immunohistochemically investigated the expression of Arp2 and Arp3 in 175 colorectal tumors in various stages of neoplastic progression. Arp2 and Arp3 showed identical expression patterns, and both were expressed in the stromal cells around neoplastic tubules or glands and in the tumor cells themselves. The frequency of expression of Arp2 and Arp3 (Arp2 and 3) by the stromal cells increased with the atypia of the colorectal neoplasms, from 5.5% (3/55) in adenoma with mild or moderate atypia, to 11.8% (2/17) in adenoma with severe atypia, 53.3% (16/30) in intramucosal carcinoma, and 91.8% (67/73) in invasive carcinoma (P<0.0001). The frequency of expression of Arp2 and 3 in the tumor cells was similar and was 1.8% (1/55) in adenoma with mild or moderate atypia, 23.5% (4/17) in adenoma with severe atypia, 23.5% (7/30) in intramucosal carcinoma, and 32.9% (24/73) in invasive carcinoma. Expression of Arp2 and 3 by the stromal cells was significantly correlated with nuclear accumulation of p53 in the tumor cells and stromal expression of CD10. These results suggest that formation of Arp2/3 complex by both neoplastic and stromal cells contributes to the increased motility of both cell types and thus provides suitable conditions for invasion.


Asunto(s)
Actinas , Adenocarcinoma/metabolismo , Adenoma/metabolismo , Neoplasias Colorrectales/metabolismo , Proteínas del Citoesqueleto/metabolismo , Proteína 2 Relacionada con la Actina , Proteína 3 Relacionada con la Actina , Adenocarcinoma/secundario , Adenocarcinoma/cirugía , Adenoma/patología , Adenoma/cirugía , Biomarcadores de Tumor/metabolismo , Neoplasias Colorrectales/patología , Neoplasias Colorrectales/cirugía , Progresión de la Enfermedad , Humanos , Técnicas para Inmunoenzimas , Invasividad Neoplásica , Neprilisina/metabolismo , Juego de Reactivos para Diagnóstico , Células del Estroma/metabolismo , Células del Estroma/patología
4.
Dig Dis Sci ; 48(12): 2247-56, 2003 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-14714609

RESUMEN

In acute inflammatory condition, little is known about the expression of the urokinase-type plasminogen activator (uPA) and its receptor (uPAR) in the gastric fibroblasts. To clarify the role of human gastric fibroblasts in acute inflammatory conditions such as gastric ulcer, the effects of interleukin (IL)-1beta and tumor necrosis factor (TNF)-alpha on the expression of uPA and uPAR, which were suggested to be associated with tissue remodeling, in gastric fibroblasts were investigated. The expression level of uPA mRNA and the amount of uPA antigen increased significantly on treatment with each concentration of IL-1beta (1 and 10 ng/ml) and 10 ng/ml TNF-alpha. On the other hand, the amounts of uPA antigen on cell surfaces were not affected significantly by IL-1beta and TNF-alpha stimulation. The expression level of uPAR mRNA increased in a dose-dependent manner on IL-1beta stimulation. The effect of indomethacin on uPA and uPAR expression in these cells was also examined. When gastric fibroblasts were treated with 50 microM indomethacin, the expression level of uPA mRNA decreased significantly, and the amount of uPA antigen in the culture medium and on cell surfaces decreased significantly with indomethacin in a dose-dependent manner. The increased uPAR mRNA expression caused by IL-1beta was reduced to the basal level by treatment with 50 microM indomethacin. Furthermore, we investigated the role of prostaglandin E2 (PGE2), which is suggested to play major roles in acute inflammation of the stomatch, on uPA and uPAR expression in gastric fibroblasts. The expression level of uPAR mRNA and the amount of uPA antigen on cell surfaces increased in a dose-dependent manner on treatment with PGE2 (10 and 50 ng/ml). These results suggest that uPA and uPAR expression in gastric fibroblasts is involved in the regulating system of PGE2 and that NSAIDs may delay healing of gastric mucosal injury in part through suppressing uPA production via inhibition of endogenous PG production.


Asunto(s)
Antiinflamatorios no Esteroideos/farmacología , Dinoprostona/farmacología , Fibroblastos/efectos de los fármacos , Receptores de Superficie Celular/efectos de los fármacos , Úlcera Gástrica/metabolismo , Activador de Plasminógeno de Tipo Uroquinasa/efectos de los fármacos , Antiinflamatorios no Esteroideos/administración & dosificación , Antígenos/metabolismo , Células Cultivadas/efectos de los fármacos , Cartilla de ADN , Relación Dosis-Respuesta a Droga , Ensayo de Inmunoadsorción Enzimática , Fibroblastos/metabolismo , Expresión Génica , Humanos , Indometacina/administración & dosificación , Indometacina/farmacología , Interleucina-1/administración & dosificación , Interleucina-1/farmacología , ARN Mensajero/análisis , Receptores de Superficie Celular/genética , Receptores de Superficie Celular/metabolismo , Receptores del Activador de Plasminógeno Tipo Uroquinasa , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Úlcera Gástrica/patología , Factor de Necrosis Tumoral alfa/administración & dosificación , Factor de Necrosis Tumoral alfa/farmacología , Activador de Plasminógeno de Tipo Uroquinasa/genética , Activador de Plasminógeno de Tipo Uroquinasa/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA